B+
Bull case
25%
Probability
Target price
$12.30
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
ADMA
ADMA BiologicsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Asceniv growth, improving utilization, strong margins, cash generation, and reiterated FY2026 guidance support continued execution upside [#SEC-8K-2026-08-05]. The ACAAI real-world evidence update could further aid adoption.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +2.8.
What can break
Asceniv utilization growth or prescriber adoption could slow, weakening the main commercial growth driver.
Momentum
26
Value
68
Sentiment
79
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $10.84 · Bull $12.30 · Bear $7.50Analysis 2026-08-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $18.67
Why
Momentum26 · Δ7d -1.6
Value68 · Δ7d -0.0
Sentiment79 · Δ7d +2.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +2.8.
Contradictions & invalidation
- • Asceniv utilization growth or prescriber adoption could slow, weakening the main commercial growth driver.
- • Bivigam demand and pricing remain pressured by competition, discounting, and market supply dynamics.
- • Revenue growth remains modest because Bivigam is under competitive pressure.
Catalyst clock
2026-11-15
ACAAI real-world evidence update
Lead driver: Sentiment · See AI snapshot
Momentum
26
9% active weight
Current posture
7d trendFlat
Δ7d
-1.6
Δ21d
-13.4
Value
68
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+1.3
Sentiment
79
62% active weight
Current posture
7d trendImproving
Δ7d
+2.8
Δ21d
+8.5
Why this grade
Composite grade A. Momentum 26.2 / Value 67.7 / Sentiment 78.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-17. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$10.84
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$7.50
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.09B
Beta
0.49
Shares Out
223.99M
P/E (TTM)
21.3
P/S (TTM)
8.78
P/FCF (TTM)
105.67
Rev YoY
+2.0%
EPS YoY
+19.3%
Gross Margin
+64.7%
Op Margin
+42.3%
Net Debt
-$7.75M
Current Ratio
6.97
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data